Sign in

What researchers published on Chronic myeloid leukaemia

8,374 papers, newest first.

Showing 20 of 1,039

  • ReviewLeukemia as the price of immunity? An evolutionary cost framework.Frontiers in cell and developmental biology
  • ReviewTreatment-Free Remission in Chronic Myeloid Leukemia: A Systematic Review of Predictors of Successful Tyrosine Kinase Inhibitor Discontinuation.Cureus
  • Systematic reviewClinical efficacy and safety of asciminib in chronic myeloid leukemia-chronic phase (CML-CP) in real-world settings: a systematic literature review.BMC cancer
  • ReviewPredictive factors for TKI discontinuation eligibility and treatment-free remission in chronic myeloid leukemia.International journal of hematology
  • ReviewEmerging BCR::ABL1 inhibitors in chronic myeloid leukemia: current advances and future directions.International journal of hematology
  • Review[Treatment strategies for chronic-phase chronic myeloid leukemia in 2026].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • ReviewChronic Myeloid Leukemia Beyond BCR::ABL1 Inhibition: Resistance Mechanisms and Emerging Therapeutic Modalities.Pharmaceuticals (Basel, Switzerland)
  • ReviewTwenty-Five Years of CML Therapy in India: A Model for Precision Oncology in a Resource-Constrained Setting.Clinical lymphoma, myeloma & leukemia
  • ReviewCurrent perspectives on high-risk genomic profiles in chronic myeloid leukemia: from bench to clinical practice.International journal of hematology
  • ReviewThe evolving landscape of tyrosine kinase inhibitors in chronic-phase chronic myeloid leukemia: A 25-year journey.Blood reviews
  • ReviewPerioperative care of patients with chronic myeloid leukemia on tyrosine kinase inhibitors.Frontiers in oncology
  • ReviewChronic myeloid leukemia in a global context: confirmatory findings and novel discoveries from a refined Japanese Cohort.Leukemia
  • ReviewRecent Advances in Chronic Myeloid Leukaemia (CML): Emerging Molecular and Immunotherapeutic Targets.Frontiers in bioscience (Landmark edition)
  • Systematic reviewTyrosine kinase inhibitors for chronic myeloid leukemia: a landscape analysis of global clinical trials based on public registries.Frontiers in pharmacology
  • ReviewRoad to treatment-free remission in chronic myeloid leukemia.International journal of hematology
  • ReviewTherapeutic ecology of the fiber-microbiota-barrier axis in leukemia: resilience, immune recovery and pharmacomicrobiomics.Frontiers in microbiology
  • ReviewPrescription Behaviour and Drug Interactions of Acid Suppressants With Tyrosine Kinase Inhibitors in Patients With Leukaemia: Data From Germany.EJHaem
  • ReviewTreatment-Free Remission in Chronic Myeloid Leukemia: Toward Precision and Personalized Approaches to Functional Cure.Cancer science
  • ReviewSOHO State of the Art Updates and Next Questions | Chronic Myeloid Leukemia in Low- and Middle-Income Countries: Increasing Access to Tyrosine Kinase Inhibitors and Supporting Treatment Free Remission.Clinical lymphoma, myeloma & leukemia
  • ReviewReframing chronic myeloid leukemia outcomes beyond survival: a perspective of quality of life and patient-centered data.Blood reviews